Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gilead Sciences, Inc. (GILD) vs Reddit Inc (RDDT) Price & Performance

Gilead Sciences, Inc.Trade
Reddit IncTrade

Price performance (Past 24H)

Key statistics

Gilead Sciences, Inc. vs Reddit Inc — how do they compare? Gilead Sciences, Inc. trades at $135.65 (market cap $168.35B), while Reddit Inc trades at $153.26 (market cap $30.05B). The key difference: Gilead Sciences, Inc. is far larger — about 5.6× Reddit Inc's market cap, and Gilead Sciences, Inc. pays a 2.42% dividend while Reddit Inc pays none. Which is the better fit depends on your goals.

GILDRDDT
Market Cap
$168.35B$30.05B
Sector
HealthMedia
52-Week High
$155.80$270.71
52-Week Low
$110.56$121.84
Enterprise Value
$191.42B$27.28B
Dividend Yield
2.42%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gilead Sciences, Inc.

Gilead Sciences (GILD) trades at $136.73, up 2.76% on the day, with a bullish technical signal and strong analyst consensus. Recent Q2 2026 earnings beat revenue estimates despite a net loss driven by acquisition costs, while HIV drug sales and raised guidance provide fundamental support. The stock is near its pivot point of $136, with resistance at $137 and support at $134.

Outlook remains positive given robust HIV franchise growth and pipeline advancements, but risks include patent cliffs, high debt, and profitability volatility. With 67% of analysts rating it a Buy and a consensus price target of $151.22, the stock offers potential upside, though investors must weigh execution risks against growth catalysts.

Reddit Inc

Reddit (RDDT) trades at $154.14, down 2.87% over 24 hours, amid bearish technical signals despite strong fundamentals. The stock shows robust revenue growth, with Q2 2026 earnings beating estimates by 31.6% and a net income margin of 31.35%. Recent news highlights CEO stock sales and AI integration efforts, while technical indicators point to resistance near $160.

Outlook remains positive based on analyst consensus with a $220.25 price target, though risks include search traffic volatility and competitive pressures. The stock's current valuation offers potential upside if user monetization and AI initiatives drive future earnings, but investors should monitor quarterly performance for sustainability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Read more on GILD

About Reddit Inc

Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.

Read more on RDDT